![]() |
![]() |
![]() |
![]() |
| Preventing HIV |
| Treating HIV |
| Living with HIV |
| For service providers |
| For health care providers |
| Access our services |
| Find organizations |
| News and events |
| About CATIE |
| Site map |
| Home |
| CATIE Ordering Centre |
TreatmentUpdate 174Volume 21 Issue 5 2009 July/August I SIDE EFFECTS AND COMPLICATIONS: D. Cystatin C for monitoring kidney healthAlthough the level of creatinine in the blood is often used to estimate the glomerular filtration rate (eGFR)—and thereby kidney health—creatinine may not always be the ideal substance to use for this purpose. Creatinine is produced when muscle cells break down, therefore, creatinine levels are dependant on the amount of muscle in the body. Also, creatinine and eGFR calculations can be affected by other factors such as posture, thyroid disease, pregnancy, exercise, blood sugar levels and so on. As a result, researchers have sought another substance with levels that are more stable in the blood, which can be used to estimate eGFR. That substance may be cystatin C. About cystatin CCystatin C is a protein produced by many of the body’s cells. It helps to protect connective tissue from breaking down and may help protect the body from infection. Under normal conditions, cystatin C levels in the blood are relatively stable, particularly under conditions where creatinine is not. Moreover, cystatin C may be particularly useful in attempting to assess cases of early or subtle kidney damage when using creatinine levels cannot reveal this damage. Cystatin C may also have other uses—high levels of this protein in the blood have been linked to an increased risk of stroke, heart attack and death. This is because high cystatin C levels suggest that inflammation is taking place, inflammation that can damage whole organ-systems. Cystatin C measurements may have multiple potential uses, but in this issue of TreatmentUpdate we focus on its use for estimating GFR. REFERENCES:
Created on: 2009 August 10 Author: Hosein SR |
|
| |
|
Decisions about particular medical treatments should always be made in consultation with a qualified medical practitioner who is knowledgeable about HIV-related illness and the treatments in question. MORE | |